Annotation Detail

Information
Associated Genes
CTLA4
Associated Variants
CTLA4 MUTATION
CTLA4 MUTATION
Associated Disease
Non-small cell lung carcinoma
Source Database
DisGeNET
Description
Recent early phase studies of immune checkpoint modulators, such as CTLA-4, PD-1 and PD-L1 inhibitors in NSCLC have reported promising results with prolonged clinical responses and tolerable toxicity.
Pubmed
24880938
Section of the abstract supporting the evidence
ALL_TEXT_3/3
Number of the section of the abstract supporting the evidence
3
Number of the sentence supporting the evidence
3
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00244297684872273
Drugs